Pathologic von Willebrand factor degradation is a major contributor to left ventricular assist device-associated bleeding: pathophysiology and evolving clinical management

被引：7
|
作者：
Bartoli, Carlo R. [1 ]
机构：
[1] Hosp Univ Penn, Div Cardiovasc Surg, 380 South Univ Ave,Hill Pavilion,Room 410B, Philadelphia, PA 19104 USA
来源：
ANNALS OF CARDIOTHORACIC SURGERY | 2021年 / 10卷 / 03期
关键词：
PULSATILITY;
D O I：
10.21037/acs-2020-cfmcs-29
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：389 / 392
页数：4
相关论文
共 50 条
  • [1] Preclinical Models for Translational Investigations of Left Ventricular Assist Device-Associated von Willebrand Factor Degradation
    Restle, David J.
    Zhang, David M.
    Hung, George
    Howard, Jessica L.
    Kallel, Faouzi
    Acker, Michael A.
    Atluri, Pavan
    Bartoli, Carlo R.
    ARTIFICIAL ORGANS, 2015, 39 (07) : 569 - 575
  • [2] Factor VIII/von Willebrand factor concentrate therapy for ventricular assist device-associated acquired von Willebrand disease
    Cushing, Melissa
    Kawaguchi, Kathy
    Friedman, Kenneth D.
    Mark, Tomer
    TRANSFUSION, 2012, 52 (07) : 1535 - 1541
  • [3] Clinical Manifestations and Management of Left Ventricular Assist Device-Associated Infections
    Nienaber, Juhsien Jodi C.
    Kusne, Shimon
    Riaz, Talha
    Walker, Randall C.
    Baddour, Larry M.
    Wright, Alan J.
    Park, Soon J.
    Vikram, Holenarasipur R.
    Keating, Michael R.
    Arabia, Francisco A.
    Lahr, Brian D.
    Sohail, M. Rizwan
    CLINICAL INFECTIOUS DISEASES, 2013, 57 (10) : 1438 - 1448
  • [4] New Treatments for Left Ventricular Assist Device-Associated Bleeding?
    Strueber, Martin
    JACC-HEART FAILURE, 2015, 3 (11) : 870 - 872
  • [5] Inhibition of ADAMTS-13 by Doxycycline Reduces von Willebrand Factor Degradation During Supraphysiological Shear Stress Therapeutic Implications for Left Ventricular Assist Device-Associated Bleeding
    Bartoli, Carlo R.
    Kang, Jooeun
    Restle, David J.
    Zhang, David M.
    Shabahang, Cameron
    Acker, Michael A.
    Atluri, Pavan
    JACC-HEART FAILURE, 2015, 3 (11) : 860 - 869
  • [6] Von Willebrand factor, a versatile player in gastrointestinal bleeding in left ventricular assist device recipients?
    Fischer, Quentin
    Huisse, Marie-Genevieve
    Voiriot, Guillaume
    Caron, Claudine
    Lepage, Laurent
    Dilly, Marie-Pierre
    Nataf, Patrick
    Ajzenberg, Nadine
    Kirsch, Matthias
    TRANSFUSION, 2015, 55 (01) : 51 - 54
  • [7] Left Ventricular Assist Device-Associated Allosensitization - Clinical Implications
    Ko, B. -S.
    Willis, C.
    Drakos, S.
    Hurst, D.
    Kfoury, A.
    Snow, G.
    Delgado, J.
    Hammond, E.
    Selzman, C.
    Alharethi, R.
    McKellar, S.
    Nativi-Nicolau, J.
    Gilbert, E.
    Revelo, P.
    Miller, D.
    Reid, B.
    Fang, J.
    Eckles, D.
    Stehlik, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [8] Outcomes of Endoscopic Evaluation for Left Ventricular Assist Device-Associated Gastrointestinal Bleeding
    Blais, Pierre
    Sparrow, Christopher T.
    Raymer, David S.
    Vader, Justin M.
    LaRue, Shane J.
    Chen, Chien-Huan
    GASTROINTESTINAL ENDOSCOPY, 2017, 85 (05) : AB208 - AB209
  • [9] Acquired von Willebrand syndrome associated with left ventricular assist device
    Nascimbene, Angelo
    Neelamegham, Sriram
    Frazier, O. H.
    Moake, Joel L.
    Dong, Jing-fei
    BLOOD, 2016, 127 (25) : 3133 - 3141
  • [10] Clinical and In Vitro Evidence That Left Ventricular Assist Device-Induced von Willebrand Factor Degradation Alters Angiogenesis
    Bartoli, Carlo R.
    Zhang, David M.
    Hennessy-Strahs, Samson
    Kang, Jooeun
    Restle, David J.
    Bermudez, Christian
    Atluri, Pavan
    Acker, Michael A.
    CIRCULATION-HEART FAILURE, 2018, 11 (09) : e004638
12345